A randomized phase 1 study of safety, tolerability, and pharmacokinetics of MK-1088, a novel dual adenosine receptor antagonist, in healthy adult participants
Article in Investigational New Drugs (August 2024)
The most recent citing publications are shown below. View all 15 publications that cite this research output on Dimensions.
Coffee and multiple sclerosis (MS)
Book chapter (July 2024)
Network pharmacology integrated with experimental validation to elucidate the mechanisms of action of the Guizhi-Gancao Decoction in the treatment of phenylephrine-induced cardiac hypertrophy
Article in Pharmaceutical Biology (May 2024)